Skip to content

Who pays to create new medicines?

Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.

Read More

Laura Gunter named to Council of State Bioscience Associations board

Laura Gunter, NCBIO president

Laura Gunter named to Council of State Bioscience Associations board Laura Gunter, NCBIO president NCBIO President Laura Gunter has been elected to the Board of Directors of the Council of State Bioscience Associations. Gunter will serve a two-year term beginning 2022.   “We are thrilled to announce our new slate of incredibly accomplished and esteemed…

Read More

Laura Gunter: Biotech policies should protect patients, innovation

Laura Gunter: Biotech policies should protect patients, innovation The ongoing response to the COVID-19 pandemic has highlighted the critical role of the North Carolina life sciences industry in battling our most serious public health threats. When faced with the threat of COVID-19, biotechnology companies — many based right here in North Carolina — answered the…

Read More

Natacha Janvier joins NCBIO as membership director

Natacha Janvier joins NCBIO as membership director Natacha Janvier has joined NCBIO as the organization’s new membership director. Janvier began her new role on Nov. 15. “We are very excited to have Natacha joining us,” said NCBIO President Laura Gunter. “She has an impressive background in North Carolina’s life sciences industry, and she will be…

Read More

Pharmaceutical Prescribing Labels: An Enormous Opportunity to Eliminate Pointless Paper Waste in the United States

Pharmaceutical Prescribing Labels: An Enormous Opportunity to Eliminate Pointless Paper Waste in the United States This post originally appeared on the website of the Environmental Paper Network. A serious approach to addressing climate change must include the proactive elimination of unnecessary paper consumption. Paper is an important and useful material that should be produced and…

Read More

BIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients

BIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients Michelle McMurry-Heath, M.D., Ph.D., president and CEO of the Biotechnology Innovation Organization, released the following statement after the House of Representatives passed the Build Back Better Act on Nov. 19: “The legislation that passed the House today will upend a successful Medicare system and…

Read More

NC colleges and universities review workforce training programs with BMF members

NC colleges and universities review workforce training programs with BMF members Representatives from the NC Community Colleges’ BioNetwork, the NC Pharmaceutical Services Network, BRITE at NC Central University, NC A&T University and North Carolina State University’s BTEC were all on hand Tuesday, Nov. 16, at the NCBIO Biomanufacturers Forum Meeting to discuss their efforts provide…

Read More

2021 NCBIO Annual Meeting returns to in-person, Samulski delivers keynote

Jude Samulski, AskBio president and CSO, at 2021 NCBIO Annual Meeting

2021 NCBIO Annual Meeting returns to in-person, Samulski delivers keynote Nearly 200 people attended NCBIO’s 2021 Annual Meeting Tuesday, Oct. 5, with almost 120 choosing to be there in person and about 75 opting to participate online.   Attendees heard discussions of drug pricing, the challenges of a launching a startup, federal issues affecting the…

Read More